For pharma, biotech, CROs and digital pathology companies

How your team works with immunotherapy biomarkers today, what TLS analysis on routine H&E would be worth to you, and how you would buy or integrate it. We are AI Immunity Hub, taking part in the ICURe Discovery programme. The questions adapt to your role, and you can skip any except your role.

Pathologist, oncologist or academic researcher? Take the clinical survey instead (about 3 minutes) →